Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07710729 UBT-251 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07710729 clinical trial report covering UBT-251, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07710664 HPV-16 targeted mRNA vaccine(Novi Technology) HPV16 Infection Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07710664 clinical trial report covering HPV-16 targeted mRNA vaccine(Novi Technology), Phase 1, endpoints, sponsor, geography, readout timing and develo
Latest Hotspot
8 min read
NCT07715149 Nomelcitinib Hepatic Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715149 clinical trial report covering Nomelcitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715136 BCMA-CD19 cCAR-T cell therapy (iCell Gene Therapeutics) Myositis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715136 clinical trial report covering BCMA-CD19 cCAR-T cell therapy (iCell Gene Therapeutics), Phase 1, endpoints, sponsor, geography, readout timing
Latest Hotspot
8 min read
NCT07713290 GKL-006 Unresectable Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07713290 clinical trial report covering GKL-006, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715175 Nomelcitinib Renal Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715175 clinical trial report covering Nomelcitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715630 Invivo Car-T(Sun-Novo) Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715630 clinical trial report covering Invivo Car-T(Sun-Novo), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07712939 CND-319 Sjogren's Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07712939 clinical trial report covering CND-319, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07713758 Repinatrabit Phenylketonurias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07713758 clinical trial report covering Repinatrabit, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07713732 TLN-499 Recurrent Lung Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07713732 clinical trial report covering TLN-499, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07714421 Polatuzumab Vedotin-Piiq High grade B-cell lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07714421 clinical trial report covering Polatuzumab Vedotin-Piiq, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715747 TJ037130 Ovarian Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715747 clinical trial report covering TJ037130, Phase 1, endpoints, sponsor, geography, readout timing and development white space.